Royal Bank of Canada »

First Tracks Biotherapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-06-30 $145k 7.3k 19.80

More positions owned by Royal Bank of Canada

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Rbc Cad (RY)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Bank Of Montreal Cadcom (BMO)
Alphabet Cap Stk Cl C (GOOG)
Cibc Cad (CM)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)

View all positions for Royal Bank of Canada

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics